Search for: "WYETH PHARMACEUTICALS COMPANY" Results 281 - 300 of 547
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Dec 2011, 5:18 am
To make matters worse, there is some evidence that the company’s Wyeth division tried to plant shoddy research in medical journals to downplay the bad results. [read post]
21 Mar 2009, 11:02 am
 To contemplate removing citizens' rights to justice and compensation in the event of an injury caused by a pharmaceutical drug or product simply because the drug has FDA approval, is a line of thinking that has just been quashed by the Supreme Court in its recent Wyeth vs. [read post]
2 Aug 2012, 10:17 am by FDABlog HPM
May 2, 2012) denying Mutual Pharmaceutical Company’s (“Mutual’s”) appeal of a decision from the U.S. [read post]
18 Jan 2013, 2:06 pm by Bexis
  The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
30 Oct 2008, 4:38 pm
Levine sued the manufacturer, Wyeth, contending the company suppressed key information and neglected its duty to warn consumers that such injections could have horrific side effects. [read post]
15 May 2008, 12:41 pm
Riegel does not bar his lawsuit but the Supreme Court will consider this Fall whether to extend the preemption umbrella to pharmaceutical drugs in Wyeth v. [read post]
15 May 2008, 12:41 pm
Riegel does not bar his lawsuit but the Supreme Court will consider this Fall whether to extend the preemption umbrella to pharmaceutical drugs in Wyeth v. [read post]
26 May 2007, 11:26 pm
Johnson & Johnson, based in New Brunswick, was granted a federal court injunction two months ago blocking Mylan from selling copycat versions until the patent expires in 2008.# Wyeth's Effexor XR, which rang up $3.5 billion in 2006 sales, is being challenged by Alza, a J&J company. [read post]
5 Jul 2013, 5:00 am by Bexis
Wyeth, Inc., 37 A.3d 549, 570 (New Jersey Super. [read post]
7 Nov 2008, 2:57 pm
Many suggested that the legal pendulum will swing away from eight years of policies broadly sympathetic to financial institutions, pharmaceutical companies and the oil industry. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
29 Mar 2007, 4:46 am
It accepts FDA regulation as sufficient, at least in part, to deter New Jersey pharmaceutical companies from manufacturing unsafe prescription drugs. . . . [read post]